Enhancements    

Patents of Marc Cox

Next Generation FKBP52 Targeting Drugs for the Treatment of Prostate and Breast Cancer
Issue Date: 01 - 23 - 2024
Application Date: 01 - 20 - 2021
Patent No. 11,878,961

PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME
Issue Date: 06 - 16 - 2020
Application Date: 05 - 17 - 2018
Patent No. 10,682,339

FKBP52-Specific Androgen Receptor Inhibitor, MJC13, for Use in Treating Breast Cancer
Issue Date: 10 - 08 - 2019
Application Date: 06 - 15 - 2017
Patent No. 10,434,075

Pharmaceutical compositions directly targeting fkbp52 for the treatment of prostate cancer and methods of using same
Issue Date: 06 - 18 - 2019
Application Date: 08 - 20 - 2015
Patent No. 10,322,113

Intravenous formulation and lc/ms/ms analysis method for gmc1
Issue Date: 07 - 03 - 2018
Application Date: 03 - 28 - 2017
Patent No. 10,010,534

Pharmaceutical Compositions Which Inhibit Fkbp52-Mediated Regulation of Androgen Receptor Function and Methods of Using Same
Issue Date: 10 - 10 - 2017
Application Date: 12 - 15 - 2015
Patent No. 9,782,399

Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function and Methods of Using Same
Issue Date: 01 - 12 - 2016
Application Date: 07 - 21 - 2014
Patent No. 9,233,973

Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function and Methods of Using Same
Issue Date: 10 - 14 - 2014
Application Date: 05 - 04 - 2012
Patent No. 8,859,207

Pharmaceutical Compositions which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function and Methods of Using Same (NIH)
Issue Date: 04 - 17 - 2014
Application Date: 09 - 14 - 2010
Patent No. AU2010295806 Australia